DGX logo
DGX NYSE US

Quest Diagnostics Incorporated Common Stock

Health Care · Health Care Sito web · IPO Dic 1996
$206,89
▲ +$10,58 (+5,39%)
Vol. 359K
Cap. mercato
$21.1B
P/E
21,2
ROE
13,9%
Margine
9,0%
Beta
0,62
Rendimento div.
1,80%
52W
$160–$214

Consenso Wall Street

24 analisti · Apr 2026
6
Acquisto forte
7
Compra
11
Mantieni
0
Vendi
0
Vendita forte
54,2%
Rating Compra

Grafico dei Prezzi

Utili

Tasso di battuta: 100,0%
Trimestre EPS Stimato EPS Effettivo Sorpresa
Dic 2025 $2,38 $2,42 +$0,04
Set 2025 $2,53 $2,60 +$0,07
Giu 2025 $2,60 $2,62 +$0,02
Mar 2025 $2,17 $2,21 +$0,04

Ricavi e utili trimestrali

Trimestre 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Ricavi $2.6B $2.7B $2.8B $2.8B $2.8B
Utile netto $222.0M $220.0M $282.0M $245.0M $245.0M

Trend fondamentali

Metrica 2026-04-12 2026-04-17
ROE (TTM) 13.9% 13.9%
P/E (TTM) 21.21 21.24
Net Margin 9.0% 9.0%
Gross Margin 33.3% 33.3%
D/E Ratio
Current Ratio 1.04 1.04

Rapporti chiave

ROA (TTM)
6,2%
P/S (TTM)
1,91
P/B
2,7
EPS (TTM)
$8,78
CF/Share
$10,91
Crescita ricavi 3A
+3,7%
52W High
$213,50
52W Low
$160,02
$160,02 Intervallo 52 settimane $213,50

Salute finanziaria

Flusso di cassa libero
$307.0M
Debito netto
$6.2B
Liquidità
$420.0M
Debito totale
$6.6B
Aggiornato al Dic 31, 2025

Як DGX виглядає на тлі конкурентів у Health Care?

Група порівняння: Peers · Health Care (Peers) · 10 компаній

Оцінка DGX vs аналоги Health Care

P/E
21,2
12% sotto peer (24,2)
vs Peer
vs Settore
Valore equo
P/S
1,9
55% sopra peer (1,2)
vs Peer
vs Settore
Sopravvalutato
P/B
2,7
2% sotto peer (2,8)
vs Peer
vs Settore
Valore equo
Дивідендна дохідність
1,7%
0% sotto peer (1,7%)
vs Peer
vs Settore
Rendimento basso

Прибутковість DGX vs аналоги Health Care

ROE
13,9%
2% sotto peer (14,2%)
vs Peer
vs Settore
In linea
Net margin
9,0%
95% sopra peer (4,6%)
vs Peer
vs Settore
Top livello
Валова маржа
33,3%
9% sopra peer (30,5%)
vs Peer
vs Settore
Top livello
ROA
6,2%
35% sopra peer (4,6%)
vs Peer
vs Settore
Top livello

Фінансове здоровʼя DGX vs аналоги Health Care

D/E ratio
0% sotto peer (139,3)
vs Peer
vs Settore
In linea
Поточна ліквідність
1,0
23% sotto peer (1,4)
vs Peer
vs Settore
Liquidità bassa
Beta
0,7
25% sotto peer (0,9)
vs Peer
vs Settore
Più volatile

Радар фундаменталів DGX

DGX Mediana peer Industria

DGX прибутковість vs борг

Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio

DGX vs аналоги: ключові метрики

Attività insider

Bullish
Acquisti
10
$21148109
Vendite
10
$4115933
WENTWORTH TIMOTHY CHARLES
Director · Mar 09
award
215 shs
DOHERTY CATHERINE T
Officer · Mar 05
sale
5558 shs
PLEWMAN PATRICK
Officer · Mar 05
sale
2855 shs
PREVOZNIK MICHAEL E
General Counsel · Mar 05
sale
3878 shs
DOHERTY CATHERINE T
Officer · Mar 04
award
11364 shs
PLEWMAN PATRICK
Officer · Mar 04
award
5682 shs
SAMAD SAMER ABDUL
Chief Financial Officer · Mar 04
award
13947 shs
DEPPE MICHAEL J
Officer · Mar 04
award
1473 shs
KUPPUSAMY KARTHIK
Officer · Mar 04
award
6200 shs
KUPPUSAMY KARTHIK
Officer · Mar 04
sale
2628 shs
Ultimo 90 giorni

Rendimenti acquisti insider

GREGG VICKY B
Gen 28, 2026
$12295 +12,74%
GREGG VICKY B
Lug 21, 2025
$13232 +23,52%
SAMAD SAMER ABDUL
Lug 21, 2025
$12060 +23,52%
PLEWMAN PATRICK
Apr 21, 2025
$13318 +25,83%
SAMAD SAMER ABDUL
Apr 21, 2025
$12167 +25,83%

Principali azionisti

Top 5: 35,85%
Vanguard Group Inc
13,00%
$2.8B
Blackrock Inc.
8,55%
$1.8B
Price (T.Rowe) Associates I…
5,69%
$1.2B
State Street Corporation
4,86%
$1.0B
JPMORGAN CHASE & CO
3,75%
$794.0M
Aggiornato al Dic 31, 2025

Dividendi

$3,26
/ anno
Apr 06, 2026 $0,8600
Gen 13, 2026 $0,8000
Ott 03, 2025 $0,8000
Lug 07, 2025 $0,8000
Apr 07, 2025 $0,8000
Gen 14, 2025 $0,7500
Ott 04, 2024 $0,7500
Lug 08, 2024 $0,7500